For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Mechanism and Efficacy of Using Polymeric Nanoparticles for Treating Atherosclerosis

Friday, December 13, 2024

1:00 PM-3:00 PM

BIOMED PhD Thesis Defense

Title:
Mechanism and Efficacy of Using Polymeric Nanoparticles for Treating Atherosclerosis

Speaker:
Yao Zhao, PhD Candidate
School of Biomedical Engineering, Science and Health Systems
Drexel University

Advisor:
Yinghui Zhong, PhD
Professor
School of Biomedical Engineering, Science and Health Systems
Drexel University

Details:
Atherosclerosis, a leading cause of cardiovascular disease, is characterized by the accumulation of lipid-laden macrophages (foam cells) in response to modified lipoproteins. As the disease progresses, advanced plaques can restrict or block blood flow, leading to severe cardiovascular complications such as heart attack and stroke. Despite the use of lipid-lowering and antiplatelet therapies, there remains a critical need for direct therapeutic strategies that can reduce plaques while simultaneously addressing the inflammatory and oxidative stress microenvironment. This study explores the potential of polysaccharide-based nanoparticles (NPs) for the treatment of atherosclerosis. We demonstrate that these nanoparticles promote cholesterol efflux from lipid-laden macrophages through the activation of multiple pathways, including ABCA1, SR-B1, and autophagy induction. Additionally, we show that apoA1 and apoE contribute to NP-mediated cholesterol efflux.

By encapsulating curcumin within the NPs (CNPs), we enhanced their anti-inflammatory and antioxidant effects. In vivo experiments in an atherosclerotic mouse model confirmed that NPs specifically target atherosclerotic plaques, resulting in reduced plaque size, stabilized plaques, and decreased inflammation, oxidative stress, and hypertriglyceridemia. Safety assessments conducted in vitro and in vivo confirm the safety of NPs and CNPs. These findings suggest that NPs and CNPs have potential as novel therapies for atherosclerosis, addressing both cholesterol efflux and the underlying inflammatory and oxidative processes.

Contact Information

Natalia Broz
njb33@drexel.edu

Remind me about this event. Notify me if this event changes. Add this event to my personal calendar.

Location

Pearlstein Business Learning Center, Room 101, located at 3230 Market Street. Also on Zoom.

Audience

  • Undergraduate Students
  • Graduate Students
  • Faculty
  • Staff